MSN Group is pleased to announce that we received USFDA APPROVAL for BUMETANIDE Injection, ANDA 1 mg/4 mL (0.25 mg/mL) Single-Dose Vials & 2.5 mg/10…
There was a problem reporting this post.
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.